These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1232 related articles for article (PubMed ID: 10073145)
1. Initial experience with sentinel node biopsy in breast cancer at the National Cancer Center Hospital East. Imoto S; Hasebe T Jpn J Clin Oncol; 1999 Jan; 29(1):11-5. PubMed ID: 10073145 [TBL] [Abstract][Full Text] [Related]
2. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial]. Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111 [TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881 [TBL] [Abstract][Full Text] [Related]
4. A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer. Kida K; Ishikawa T; Yamada A; Shimizu D; Tanabe M; Sasaki T; Ichikawa Y; Endo I Eur J Surg Oncol; 2015 Apr; 41(4):566-70. PubMed ID: 25650249 [TBL] [Abstract][Full Text] [Related]
5. Initial experience in a community hospital with sentinel lymph node mapping and biopsy for evaluation of axillary lymph node status in palpable invasive breast cancer. Morgan A; Howisey RL; Aldape HC; Patton RG; Rowbotham RK; Schmidt EK; Simrell CR J Surg Oncol; 1999 Sep; 72(1):24-30; discussion 30-1. PubMed ID: 10477872 [TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node mapping in early-stage breast cancer: technical issues and results with vital blue dye mapping and radioguided surgery. Canavese G; Gipponi M; Catturich A; Di Somma C; Vecchio C; Rosato F; Percivale P; Moresco L; Nicolò G; Spina B; Villa G; Bianchi P; Badellino F J Surg Oncol; 2000 May; 74(1):61-8. PubMed ID: 10861612 [TBL] [Abstract][Full Text] [Related]
7. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Giuliano AE; Kirgan DM; Guenther JM; Morton DL Ann Surg; 1994 Sep; 220(3):391-8; discussion 398-401. PubMed ID: 8092905 [TBL] [Abstract][Full Text] [Related]
8. [Demonstration of the sentinel lymph node in axillary dissection for breast cancer]. Salmon RJ; Fried D Presse Med; 1998 Mar; 27(11):509-12. PubMed ID: 9767960 [TBL] [Abstract][Full Text] [Related]
9. Initial experience in a cancer hospital in Nepal with sentinel lymph node mapping and biopsy for evaluation of axillary lymph node status in palpable invasive breast cancer. Lamichhane N; Pradhan M; Neupane PR; Shrestha BM; Dhakal HP; Thakur BK; Cox CE Nepal Med Coll J; 2007 Mar; 9(1):22-6. PubMed ID: 17593673 [TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer. Brady EW Breast J; 2002; 8(2):97-100. PubMed ID: 11896755 [TBL] [Abstract][Full Text] [Related]
11. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757 [TBL] [Abstract][Full Text] [Related]
12. Use of methylene blue dye for lymphatic basin mapping and sentinel lymph node biopsy in breast cancer patients in Enugu, Nigeria. Okoye CL; Ezeome ER Niger J Clin Pract; 2022 Nov; 25(11):1805-1811. PubMed ID: 36412286 [TBL] [Abstract][Full Text] [Related]
13. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer. Li J; Jia S; Zhang W; Qiu F; Zhang Y; Gu X; Xue J BMC Surg; 2015 Jun; 15():79. PubMed ID: 26123412 [TBL] [Abstract][Full Text] [Related]
14. Gamma-probe-guided resection of the sentinel lymph node in breast cancer. Crossin JA; Johnson AC; Stewart PB; Turner WW Am Surg; 1998 Jul; 64(7):666-8; discussion 669. PubMed ID: 9655279 [TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye. Kern KA J Am Coll Surg; 1999 Dec; 189(6):539-45. PubMed ID: 10589589 [TBL] [Abstract][Full Text] [Related]
16. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer. Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301 [TBL] [Abstract][Full Text] [Related]
17. Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection. van der Ploeg IM; Tanis PJ; Valdés Olmos RA; Kroon BB; Rutgers EJ; Nieweg OE Ann Surg Oncol; 2008 Nov; 15(11):3239-43. PubMed ID: 18773244 [TBL] [Abstract][Full Text] [Related]
18. Predictive value of intraoperative touch preparation analysis of sentinel lymph nodes for axillary metastasis in breast cancer. Mullenix PS; Carter PL; Martin MJ; Steele SR; Scott CL; Walts MJ; Beitler AL Am J Surg; 2003 May; 185(5):420-4. PubMed ID: 12727560 [TBL] [Abstract][Full Text] [Related]
19. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients? Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642 [TBL] [Abstract][Full Text] [Related]
20. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study. Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]